StartUs Insights, a high-performance platform that identifies global startups, scaleups, and technologies, analyzed 564 chronic disease management startups. They pinpointed the top 5 solutions based on a series of criteria like relevancy and impact. EveryDose was selected as one of the 5 most promising startups. The vast majority of patients with chronic disease depend on prescription medication to maintain their health and yet, there is high nonadherence in chronic disease patients. Reasons for nonadherence include “complex medication regimes, poor understanding of dose or schedule, or lapses in memory” as StartUs Insights mentioned in the article. EveryDose’s app helps users stay adherent with their meds while educating them about their prescriptions and overall health. Read how in the StartUs Insights article here.
Other startups listed in the top 5 alongside EveryDose were a telehealth platform, health management platforms, and a personalized digital health coach. It is evident that technology plays an essential role in advancing chronic disease management. EveryDose will continue in our efforts to improve patient lives, for those with chronic diseases and those without, one dose at a time.
